Purchase Order 75N95023P00724
Award Date
9/5/23
Potential Completion Date
11/5/23
Potential Value
$13K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NIH NCATS) awarded a $122,612.40 firm fixed-price purchase order to Horizon Discovery Biosciences LIMITED, a foreign-owned for-profit manufacturer, for 14 Mouse ON-TARGET plus small interfering RNA (siRNA) libraries. This non-competitive, brand-name acquisition was conducted under simplified acquisition procedures without any small business set-aside. The purchase...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $30,316.20 firm fixed price purchase order to Horizon Discovery Biosciences Limited, located in Great Britain, United Kingdom. The contract is for unspecified products or services to be delivered between July 12, 2023 and July 22, 2023 in support of NIH's efforts to enhance the development, testing, and implementation of translational sciences. Horizon...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $202,000.00 firm fixed price purchase order to Horizon Discovery Biosciences LIMITED, a foreign-owned for-profit manufacturer, for the "SIRNAS WITH ACCELL MODIFICATION PROJECT". The contract, which does not have a small business set-aside, is for the provision of various gene silencing and regulation products, including small interfering...
Horizon Discovery Biosciences LIMITED has been awarded a firm fixed price purchase order totaling one hundred twenty-one thousand two hundred ninety-four dollars and sixty-four cents ($121,294.64) by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to supply a Dharmacon Human On-TargetPlus Druggable Genome siRNA Library for the Functional Genomic Lab. The purchase order does not include any set-aside designations...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $12,235.00 firm-fixed-price purchase order contract to Horizon Discovery Limited, a for-profit biotechnology company based in the United Kingdom. The contract is for the provision of custom human cell lines to support biomedical research, with a completion date of December 13, 2019. No set-aside was used for this award. Horizon Discovery...
This $14,810.64 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Horizon Discovery Biosciences LIMITED, a foreign-owned, for-profit manufacturer of genetic research materials. The award is for the supply of Horizon Discovery's SMARTVECTOR human whole genome lentiviral shRNA pooled library and associated USB plate map files. This specialized genetic...
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH), to Horizon Discovery Limited, a UK-based biotechnology company, for whole-genome CRISPR knockout gene interaction screening services. The contract, valued at $92,500, was awarded in support of NICHD research to translate genomic and genetic research into a greater understanding of human genetic disease and the...
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, to Dharmacon, Inc., a foreign-owned for-profit company, for the delivery of DHARMACON OTP MOUSE DRUGGABLE SET OF 4, 0.1 NM. The contract was set aside for small businesses, with a ceiling value of $92,029.00 and a completion date of August 10, 2020. The contract originated from a solicitation for custom RNA interference...
This is a $249,167.58 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotech company. The contract is for the development of humanized mouse models for nicotinamide N-methyltransferase (NNMT) and sulfotransferase (SULT1A1) using CRISPR knock-in technology. The contractor will conduct biochemical testing of inhibitors and...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed-price purchase order to Eurofins Discoverx Products, LLC, a foreign-owned, self-certified small disadvantaged business, for a PathHunter Detection Kit. The potential value of the contract is $30,778.40, with a completion date of August 25, 2021. The services provided under this contract appear to be in support of the agency's mission of advancing...